US2003149279A1PendingUtilityA1
Process for the production of amorphous atorvastatin calcium
Priority: May 25, 1999Filed: Mar 3, 2003Published: Aug 7, 2003
Est. expiryMay 25, 2019(expired)· nominal 20-yr term from priority
A61P 3/06C07D 207/34
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for the preparation of amorphous atorvastatin calcium and hydrates thereof which comprises: (a) dissolving crystalline atorvastatin calcium in a non-hydroxylic solvent; (b) adding a non-polar hydrocarbon anti-solvent or adding the dissolved atorvastatin to the non-polar anti-solvent to precipitate out atorvastatin calcium; and (c) removing the solvent by filtration to afford amorphous atorvastatin calcium.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A process for the preparation of amorphous atorvastatin calcium and hydrates thereof which comprises:
(a) dissolving crystalline atorvastatin calcium in a non-hydroxylic solvent; (b) adding a non-polar hydrocarbon anti-solvent or adding the dissolved atorvastatin to the non-polar anti-solvent to precipitate out atorvastatin calcium; and (c) removing the solvent by filtration to afford amorphous atorvastatin calcium.
2 . The process of claim 1 , wherein the non-hydroxylic solvent is tetrahydrofuran and anti-solvent is chosen from a group of non-polar hydrocarbon solvents comprising n-hexane, cyclohexane or n-heptane.
3 . The process of claim 1 , wherein the non-hydroxylic solvent is tetrahydrofuran and anti-solvent is n-hexane.
4 . The process of claim 1 , wherein the non-hydroxylic solvent is tetrahydrofuran and anti-solvent is cylcohexane.
5 . The process of claim 1 , wherein the non-hydroxylic solvent is tetrahydrofuran and anti-solvent is n-heptane.
6 . The process of claim 1 , wherein said amorphous atorvastatin calcium is isolated by filtration.Join the waitlist — get patent alerts
Track US2003149279A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.